{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:14:02Z","timestamp":1768443242533,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,11]],"date-time":"2011-02-11T00:00:00Z","timestamp":1297382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s11926-011-0168-8","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T12:10:10Z","timestamp":1297339810000},"page":"273-282","source":"Crossref","is-referenced-by-count":15,"title":["Potential and Pitfalls of Using Large Administrative Claims Data to Study the Safety of Osteoporosis Therapies"],"prefix":"10.1007","volume":"13","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifeng","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth G.","family":"Saag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Delzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,11]]},"reference":[{"issue":"3","key":"168_CR1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11926-010-0097-y","volume":"12","author":"DJ Becker","year":"2010","unstructured":"Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep. 2010;12(3):186\u201391.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"168_CR2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","volume":"24","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen B, Eiken P, Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009;24(6):1095\u2013102.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"168_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-009-0962-6","volume":"21","author":"JW Nieves","year":"2010","unstructured":"Nieves JW, Bilezikian JP, Lane JM, et al. Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int. 2010;21(3):399\u2013408.","journal-title":"Osteoporos Int"},{"issue":"1","key":"168_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14219\/jada.archive.2008.0016","volume":"139","author":"VM Cartsos","year":"2008","unstructured":"Cartsos VM, Zhu S, Zavras AI. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714, 217 people. J Am Dent Assoc. 2008;139(1):23\u201330.","journal-title":"J Am Dent Assoc"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"c4444","DOI":"10.1136\/bmj.c4444","volume":"341","author":"J Green","year":"2010","unstructured":"Green J, Czanner G, Reeves G, et al. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ. 2010;341:c4444.","journal-title":"BMJ"},{"issue":"6","key":"168_CR6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.2010.1098","volume":"304","author":"CR Cardwell","year":"2010","unstructured":"Cardwell CR, Abnet CC, Cantwell MM, Murray LJ. Exposure to oral bisphosphonates and risk of esophageal cancer. JAMA. 2010;304(6):657\u2013663.","journal-title":"JAMA"},{"issue":"2","key":"168_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.clpt.6100249","volume":"82","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther. 2007;82(2):143\u2013156.","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"168_CR8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.21404","volume":"44","author":"HT Sorensen","year":"2006","unstructured":"Sorensen HT, Lash TL, Rothman KJ. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology. 2006;44(5):1075\u20131082.","journal-title":"Hepatology"},{"issue":"19","key":"168_CR9","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, et al. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010;362(19):1761\u20131771.","journal-title":"N Engl J Med"},{"issue":"18","key":"168_CR10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1001\/jama.298.18.2185","volume":"298","author":"BM Psaty","year":"2007","unstructured":"Psaty BM, Korn D. Congress responds to the IOM drug safety report\u2013in full. JAMA. 2007;298(18):2185\u20132187.","journal-title":"JAMA"},{"issue":"4","key":"168_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","volume":"58","author":"S Schneeweiss","year":"2005","unstructured":"Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323\u2013337.","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"168_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ncprheum0652","volume":"3","author":"S Suissa","year":"2007","unstructured":"Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects\u2013advantages and disadvantages. Nat Clin Pract Rheumatol. 2007;3(12):725\u2013732.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"10 Supl 2","key":"168_CR13","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/MLR.0b013e318070c08e","volume":"45","author":"S Schneeweiss","year":"2007","unstructured":"Schneeweiss S, Patrick AR, Sturmer T, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45(10 Supl 2):S131\u2013142.","journal-title":"Med Care"},{"issue":"10 Supl 2","key":"168_CR14","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/MLR.0b013e318041385f","volume":"45","author":"LM Greenwald","year":"2007","unstructured":"Greenwald LM. Medicare part D data: major changes on the horizon. Med Care. 2007;45(10 Supl 2):S9\u2013S12.","journal-title":"Med Care"},{"issue":"9","key":"168_CR15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-009-0835-z","volume":"20","author":"H Cheng","year":"2009","unstructured":"Cheng H, Gary LC, Curtis JR, et al. Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data. Osteoporos Int. 2009;20(9):1507\u20131515.","journal-title":"Osteoporos Int"},{"issue":"7","key":"168_CR16","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2009-2778","volume":"95","author":"AR Patrick","year":"2010","unstructured":"Patrick AR, Brookhart MA, Losina E, et al. The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab. 2010;95(7):3251\u20133259.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"168_CR17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00198-008-0772-2","volume":"20","author":"JR Curtis","year":"2009","unstructured":"Curtis JR, Westfall AO, Cheng H, et al. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction. Osteoporos Int. 2009;20(6):973\u2013978.","journal-title":"Osteoporos Int"},{"key":"168_CR18","unstructured":"National Osteoporosis Foundation. Clinician\u2019s guide to prevention and treatment of osteoporosis (2010)."},{"issue":"20","key":"168_CR19","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMp1006189","volume":"363","author":"NK Choudhry","year":"2010","unstructured":"Choudhry NK, Shrank WH. Four-dollar generics\u2014increased accessibility, impaired quality assurance. N Engl J Med. 2010;363(20):1885\u20131887.","journal-title":"N Engl J Med"},{"issue":"3","key":"168_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/aje\/kwn135","volume":"168","author":"S Suissa","year":"2008","unstructured":"\u2022 Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008;168(3):329\u2013335. This article empirically demonstrated how immeasurable time bias can distort the results of a pharmacoepidemiologic study and evaluated the application of various methods to correct for the bias.","journal-title":"Am J Epidemiol"},{"key":"168_CR21","doi-asserted-by":"crossref","unstructured":"Cramer J, Roy A, Burrell A. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(44\u201347).","DOI":"10.1111\/j.1524-4733.2007.00213.x"},{"issue":"4","key":"168_CR22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/2040622310376137","volume":"1","author":"M Nikitovic","year":"2010","unstructured":"Nikitovic M, Solomon D, Cadarette S. Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations. Ther Adv Chron Dis. 2010;1(4):149\u2013163.","journal-title":"Ther Adv Chron Dis"},{"issue":"8","key":"168_CR23","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8):565\u2013574. discussion 75-7.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"168_CR24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.mlr.0000207817.32496.cb","volume":"44","author":"R Grymonpre","year":"2006","unstructured":"Grymonpre R, Cheang M, Fraser M, et al. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44(5):471\u2013477.","journal-title":"Med Care"},{"issue":"9","key":"168_CR25","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1359\/jbmr.080418","volume":"23","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Westfall AO, Cheng H, et al. Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101, 038 new bisphosphonate users. J Bone Miner Res. 2008;23(9):1435\u20131441.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"168_CR26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/aje\/kwq111","volume":"172","author":"B Virnig","year":"2010","unstructured":"\u2022 Virnig B, Durham SB, Folsom AR, Cerhan J. Linking the Iowa Women\u2019s Health Study cohort to Medicare data: linkage results and application to hip fracture. Am J Epidemiol. 2010;172(3):327\u2013333. This article presented the linkage of data from a conventional prospective cohort study to Medicare data and compared the data from the two sources with regard to the occurrence of hip fracture and postfracture mortality. The authors demonstrated that the incidences of both outcomes were underestimated using self-reported data.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"168_CR27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1542-4758.2008.00312.x","volume":"12","author":"WL St Peter","year":"2008","unstructured":"\u2022 St Peter WL, Liu J, Weinhandl ED, Fan Q. Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results. Hemodial Int. 2008;12(4):480\u2013491. This article presented the linkage of data from multicenter, randomized, open-label trials to Medicare end-stage renal disease data. Significantly, 287 more deaths were identified using Medicare data that were not captured in the original trial.","journal-title":"Hemodial Int"},{"issue":"11","key":"168_CR28","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25(11):2267\u20132294.","journal-title":"J Bone Miner Res"},{"issue":"10 (supplement)","key":"168_CR29","first-page":"S1573","volume":"62","author":"P Narongroeknawin","year":"2010","unstructured":"Narongroeknawin P, Patkar NM, Shakoory B, et al. Validation of diagnostic codes for subtrochanteric, diaphyseal, and typical hip fractures using administrative claims data. Arthritis Rheum. 2010;62(10 (supplement)):S1573.","journal-title":"Arthritis Rheum"},{"issue":"13","key":"168_CR30","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","volume":"99","author":"GS Wilkinson","year":"2007","unstructured":"Wilkinson GS, Kuo YF, Freeman JL, Goodwin JS. Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis. J Natl Cancer Inst. 2007;99(13):1016\u20131024.","journal-title":"J Natl Cancer Inst"},{"issue":"S1","key":"168_CR31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/pds.1806","volume":"18","author":"P Tennis","year":"2009","unstructured":"Tennis P, Zavras A, Laskarides C, Tan H. Predictive value of ICD and CPT codes for identifying osteonecrosis of the jaw (ONJ). Pharmacoepidemiol Drug Saf. 2009;18(S1):S1\u2013S273.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"168_CR32","doi-asserted-by":"crossref","unstructured":"Taylor AJ, Gary LC, Arora T, et al. Clinical and demographic factors associated with fractures among older Americans. Osteoporos Int. 2010.","DOI":"10.1007\/s00198-010-1300-8"},{"issue":"6","key":"168_CR33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00198-007-0502-1","volume":"19","author":"M Pazianas","year":"2008","unstructured":"Pazianas M, Blumentals WA, Miller PD. Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker. Osteoporos Int. 2008;19(6):773\u2013779.","journal-title":"Osteoporos Int"},{"issue":"9422","key":"168_CR34","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(04)16261-2","volume":"363","author":"JP Vandenbroucke","year":"2004","unstructured":"Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet. 2004;363(9422):1728\u20131731.","journal-title":"Lancet"},{"issue":"12","key":"168_CR35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","volume":"53","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53(12):1258\u20131267.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"168_CR36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","volume":"20","author":"S Schneeweiss","year":"2009","unstructured":"\u2022 Schneeweiss S, Rassen JA, Glynn RJ, et al. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512\u2013522. This article presented a multistep algorithm that identifies, prioritizes, and selects covariates to be used to construct a high-dimensional propensity score to adjust for confounding using administrative databases. The authors further applied and tested the algorithm in two separation studies and demonstrated that the algorithm performed better compared with using only predefined covariates.","journal-title":"Epidemiology"},{"issue":"6","key":"168_CR37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u2013619.","journal-title":"J Clin Epidemiol"},{"key":"168_CR38","doi-asserted-by":"crossref","unstructured":"Kim SY, Schneeweiss S, Katz JN, et al. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res. 2010.","DOI":"10.1002\/jbmr.288"},{"issue":"1","key":"168_CR39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.aje.a115111","volume":"129","author":"JJ Beaumont","year":"1989","unstructured":"Beaumont JJ, Steenland K, Minton A, Meyer S. A computer program for incidence density sampling of controls in case-control studies nested within occupational cohort studies. Am J Epidemiol. 1989;129(1):212\u2013219.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"168_CR40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","volume":"38","author":"S Schneeweiss","year":"2003","unstructured":"Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103\u20131120.","journal-title":"Health Serv Res"},{"issue":"1","key":"168_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355.","journal-title":"Biometrika"},{"issue":"1","key":"168_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0962280208092347","volume":"18","author":"PG Arbogast","year":"2009","unstructured":"Arbogast PG, Ray WA. Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res. 2009;18(1):67\u201380.","journal-title":"Stat Methods Med Res"},{"issue":"11","key":"168_CR43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","volume":"351","author":"WA Ray","year":"2004","unstructured":"Ray WA, Murray KT, Meredith S, et al. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med. 2004;351(11):1089\u20131096.","journal-title":"N Engl J Med"},{"issue":"9","key":"168_CR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/MLR.0b013e318179253b","volume":"46","author":"JR Curtis","year":"2008","unstructured":"Curtis JR, Cheng H, Delzell E, et al. Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example. Med Care. 2008;46(9):969\u2013975.","journal-title":"Med Care"},{"issue":"4","key":"168_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2010.920","volume":"304","author":"DJ Graham","year":"2010","unstructured":"Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA. 2010;304(4):411\u2013418.","journal-title":"JAMA"},{"key":"168_CR46","unstructured":"FDA Approves Amgen\u2019s XGEVA(TM) (Denosumab) for the prevention of skeletal-related events in patients with bone metastases from solid tumors. Available at http:\/\/wwwext.amgen.com\/media\/media_pr_detail.jsp?year=2010&releaseID=1498709 ."},{"key":"168_CR47","volume-title":"Textbook of pharmacoepidemiology","year":"2006","unstructured":"Strom BL, Kimmel SE, editors. Textbook of pharmacoepidemiology. Chichester: Wiley; 2006."},{"issue":"3","key":"168_CR48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00432-009-0662-9","volume":"136","author":"TI Jung","year":"2010","unstructured":"Jung TI, Hoffmann F, Glaeske G, Felsenberg D. Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy. J Cancer Res Clin Oncol. 2010;136(3):363\u2013370.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"168_CR49","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1007\/s10620-010-1198-1","volume":"55","author":"DM Nguyen","year":"2010","unstructured":"Nguyen DM, Schwartz J, Richardson P, El-Serag HB. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus. Dig Dis Sci. 2010;55(12):3404\u20133407.","journal-title":"Dig Dis Sci"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-011-0168-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-011-0168-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T12:58:17Z","timestamp":1559998697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-011-0168-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s11926-011-0168-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,11]]}}}